CHAPEL HILL, NC & TORONTO & LONDON & ZUG, Switzerland–(BUSINESS WIRE)– AESARA is pleased to announce the appointment of Rohit Borker as Vice President, Oncology, at AESARA, a digital market access agency that develops innovative and trusted solutions to drive transformative market access.
“Rohit brings extensive experience in oncology market access and health economics and outcomes research (HEOR) that will provide an infusion of critical subject matter expertise to AESARA’s growing presence in the field of oncology globally,” said Sissi Pham, CEO of AESARA.
With over 20 years of experience in the pharmaceutical industry, Rohit’s experiences span multiple RWE initiatives assessing and quantifying the value and economics of precision medicine, including next-generation sequencing (NGS ) and on different tumors in various clinical practice settings. Rohit has completed several Value Based Pricing (VBP) initiatives and HTA models to influence drug pricing at the C-Suites, Outcome and Value Based Contracts (OBC/VBC) level with multiple payer systems organized. He also recently developed innovative strategy and tactics for US HTAs, including ICER.
Chad Patel, US Head of Strategic Partnerships, added, “AESARA’s oncology vision is very much aligned with Rohit’s career aspirations to build our personalized Oncology Center of Excellence based on need. of our customers by bringing innovative oncology assets to more patients, based on evidence and with our value and access to strategic thinking.
AESARA is a market access agency whose goal is to impact healthcare decision-making to improve people’s lives. Founded in 2016, we are a women- and minority-owned company with seasoned biopharmaceutical industry professionals in the United States, Canada and Europe. Our diverse team is passionate about delivering our clients’ transformative market access strategies and innovative digital communication solutions. For more information, please visit www.aesara.com and connect with AESARA on Twitter and LinkedIn.